Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ACADIA PHARMACEUTICALS INC | Director | Common Stock | 34.7K | $587K | $16.94 | May 29, 2024 | Direct |
ACADIA PHARMACEUTICALS INC | Director | Restricted Stock Units | 9.39K | $159K | $16.94 | May 29, 2024 | Direct |
DBV Technologies S.A. | Director | Ordinary Shares | 20K | $34.8K | $1.74 | Aug 1, 2023 | Direct |
IDERA PHARMACEUTICALS, INC. | CHIEF OPERATING OFFICER | Stock Option (Right to Buy) | 66.5K | Jul 6, 2022 | Direct | ||
ACADIA PHARMACEUTICALS INC | Director | Director Stock Options (Right to Buy) | 16K | May 29, 2024 | Direct | ||
KalVista Pharmaceuticals, Inc. | Director | Director Stock Option (Right to Buy) | 10K | Sep 30, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACAD | ACADIA PHARMACEUTICALS INC | May 29, 2024 | 4 | $0 | 4 | May 31, 2024 | Director |
DBVT | DBV Technologies S.A. | Aug 1, 2023 | 1 | $24.3K | 4 | Aug 3, 2023 | Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Jul 6, 2022 | 1 | $0 | 4 | Jul 7, 2022 | CHIEF OPERATING OFFICER |
ACAD | ACADIA PHARMACEUTICALS INC | Jun 7, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Apr 1, 2022 | 1 | $0 | 4 | Apr 4, 2022 | CHIEF OPERATING OFFICER |
IDRA | IDERA PHARMACEUTICALS, INC. | Jan 24, 2022 | 1 | $0 | 4 | Jan 26, 2022 | CHIEF OPERATING OFFICER |
KALV | KalVista Pharmaceuticals, Inc. | Sep 30, 2021 | 1 | $0 | 4 | Oct 1, 2021 | Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Jul 8, 2021 | 1 | $0 | 4 | Jul 12, 2021 | CHIEF OPERATING OFFICER |
ACAD | ACADIA PHARMACEUTICALS INC | Jun 22, 2021 | 8 | $0 | 4 | Jun 5, 2023 | Director |
ACAD | ACADIA PHARMACEUTICALS INC | Jun 22, 2021 | 2 | $0 | 4 | Jun 24, 2021 | Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Jun 18, 2021 | 1 | $59.5K | 4 | Jun 21, 2021 | CHIEF OPERATING OFFICER |
DBVT | DBV Technologies S.A. | Jun 10, 2021 | 1 | $48.7K | 4 | Jun 11, 2021 | Director |